broad spectrum of interactions with GPCRs. In recent years, extensive research has identified and categorized numerous interacting partners of GPCRs and revealed the GPRASP family [1, 2] . In addition to their postulated role in the modulation of the postendocytic sorting of these receptors, recent data indicate that some of the GPRASP family members may modulate the transcriptional activity of the cell. The p60 transcription regulator protein (p60TRP), also known as GASP3 or BHLHB9, is one novel member of this recently discovered GPRASP family [3, 4] . Amongst the many distinguishing features of p60TRP it is noteworthy that it contains a myc-type bHLH-like domain at its C terminus which is a protein structural motif that characterizes transcription factors. Our studies have also shown that p60TRP regulates endocytic recycling of the ␦ -opioid receptor and is a predominant nervous system-associated protein that localizes to both the cytoplasm and the nucleus of cells [3, 4] .
Our newly established transgenic p60TRP mice consistently revealed a tendency to repair Alzheimer's disease (AD)-related deficits by facilitating the proteolytic cleavage of the amyloid precursor protein towards the non-amyloidogenic pathway, higher synaptic plasticity as well as cognitive functions [4] . We applied the 2-dimensional (2D) liquid chromatography coupled with tandem mass spectrometry-based isobaric tag for relative and absolute quantification (2D-LC-MS/MS iTRAQ) technique into our clinically relevant in vivo mouse model for quantitative profiling of p60TRP-regulated brain-region-specific genes. Subsequently, we generated the proteome comprising the regulated proteins from the transgenic p60TRP mouse-derived brain ( fig. 1 ). Our results show for the first time the long-term in vivo effect of neuronal p60TRP overexpression on brain-region-specific proteome changes and its potential implication for brain functions.
Materials and Methods

Reagents
Unless indicated, all reagents used for biochemical methods were purchased from Sigma-Aldrich (St. Louis, Mo., USA). Materials and reagents for SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel electrophoresis) were from Bio-Rad (Bio-Rad Laboratories, Hercules, Calif., USA). The iTRAQ reagent multiplex kit was bought commercially (Applied Biosystems, Foster City, Calif., USA).
Antibodies
Anti-Acadl (acyl-coenzyme A dehydrogenase, long-chain, 1: 1,000, rabbit polyclonal; Abcam, Cambridge, UK), anti-Gapdh (glyceraldehyde-3-phosphate dehydrogenase, 1: 3,000, mouse monoclonal; Santa Cruz Biotechnology Inc., Santa Cruz, Calif., USA), anti-Mbp (myelin basic protein, 1: 200, rat monoclonal; Abcam), anti-Mtap2 (microtubule-associated protein 2, 1: 1,000, rabbit polyclonal; Abcam), anti-Sept2 (septin 2, 1: 200, goat polyclonal; Santa Cruz Biotechnology), anti-Snca [synuclein ( ␣ ), 1: 1,000, mouse monoclonal; Santa Cruz Biotechnology], antiSncb (synuclein ( ␤ ), 1: 1,000, mouse monoclonal; Santa Cruz Biotechnology), anti-Sod1 (superoxide dismutase 1, 1: 1,500, rabbit polyclonal; Abcam), anti-Synj1 (synaptojanin 1, polyphosphoinositide phosphatase, 1: 1,000, rabbit polyclonal, mouse monoclonal; BD Biosciences, Clontech, Palo Alto, Calif., USA) and anti-Tuba8 (tubulin, ␣ 8 , 1: 2,000, mouse monoclonal; Abcam).
Animal Material
Experimental procedures, including the killing of animals, were in accordance with the International Guiding Principles for Animal Research (World Health Organization) and were approved by the local Institutional Animal Care and Use Committee (Nanyang Technological University Institutional Animal Care and Use Committee). Throughout all protocols, mice were provided with food and water ad libitum and maintained in controlled conditions (12-hour light-dark cycle, 25 ° C). All offspring were weaned onto standard chow at 21 days of age, and metabolic tissue parameters were assessed at 18 months of age. Mouse tissues, i.e. from p60TRP transgenic mice [4] and control wild-type litter mates (C57BL/6J), were isolated after humane killing of the animals using approved anaesthetic methods. To analyse the tissue-specific protein expression, all efforts were made to minimize animal suffering and to reduce the number of animals used [4, 5] .
Brain-Tissue-Specific Protein Expression Analysis
Brain tissues (cortex (Cx) and hippocampus (Hp)) were isolated from adult (approx. 18 months) transgenic p60TRP mice and wild-type litter mates (each group consisting of 3 males and 3 females, i.e. 6 mice) from each mouse strain tg38 and tg31, for both batches B-I and B-II, respectively ( fig. 1 ) . Briefly, tissues were excised, snap-frozen in liquid nitrogen, and then powdered using Fig. 1 . Schematic representation of the experimental design showing biological and technical replicates. Brain tissues were isolated from adult (approx. 18 months) transgenic p60TRP mice (tg) and wild-type litter mates (wt), each group (B-I and B-II) consisting of 3 males and 3 females, separately for each brain area (Cx and Hp) and for each mouse strain (tg38 and tg31); for B-I: 6 tg31 Cx and 6 tg31 Hp, 6 tg38 Cx and 6 tg38 Hp, 6 wt Cx and 6 wt Hp; for B-II: 6 tg31 Cx and 6 tg31 Hp, 6 tg38 Cx and 6 tg38 Hp, 6 wt Cx and 6 wt Hp. Following brain-derived tissue lysis, protein extracts were acetone precipitated, quantified, run on SDS-PAGE and subsequently digested. The quantitative proteomics analyses of transgenic p60TRP mouse-derived brains were performed by labelling with multiplex iTRAQ reagents (113-118) followed by electrostatic repulsion-hydrophilic interaction chromatography (ERLIC)-based fractionation, and LC-MS/MS-based multidimensional protein identification technology. The obtained data was analysed using ProteinPilot software and validated by quantitative Western blots. Finally, proteins were functionally classified into various subgroups. a mortar and pestle. Upon the addition of lysis buffer [2% SDS, 0.5 M triethyl ammonium bicarbonate buffer, 1 Complete TM protease inhibitor cocktail tablet (Roche, Mannheim, Germany) and 1 PhosSTOP phosphatase inhibitor cocktail tablet (Roche)], the samples were vortexed for 1 min and incubated on ice for an additional 45 min prior to homogenization (sonication parameters: amplitude, 23%; pulse: 5 s/5 s for 5 min) using a Vibra Cell highintensity ultrasonic processor (Jencons Scientific Ltd., Leighton Buzzard, UK). After centrifugation (20,000 g /4 ° C/30 min), the supernatant was collected and stored at -80 ° C until further use. The protein concentration was quantified by a '2-D Quant' kit (Amersham, Piscataway, N.J., USA) according to the manufacturer's protocol.
iTRAQ Protocol A detailed description of the 2D-LC-MS/MS iTRAQ procedures [6, 7] , including postproteomic data verification by SDS-PAGE/Western blot analyses [8, 9] , can be found in the online supplementary document (for all online suppl. material, see www. karger.com/doi/10.1159/000343672) as described previously.
Experimental Design Six wild-type mice (3 males, 3 females) and 6 transgenic mice (3 males, 3 females, for each mouse strain) were used. For each set (B-I and B-II), we used 6 samples to perform iTRAQ (6 wild-type Cxs and Hps and 6 transgenic Cxs and Hps from both mouse strains, respectively, i.e. tg31-Cx, tg31-Hp, tg38-Cx, tg38-Hp) as 6 pooled biological replicates. All experiments were performed twice (B-I and B-II; fig. 1 ) with each set repeated 6 times (separately for each area, Cx and Hp, and for each mouse strain, tg38 and tg31, respectively). This was to ensure high confidence in the detection of brain-region-specific proteins regulated by neuronal p60TRP expression. The quality of the data set and instrumental reproducibility was then confirmed by comparing and combining 3 technical replicates [6] after the samples had been labelled with 113, 114, 115, 116, 117 and 118 isobaric tags and processed by LC-MS/MS.
In order to verify that the protein samples were indeed from the whole brain tissue proteome, the identified proteins were uploaded into JVirGel (http://www.jvirgel.de/), a database that creates a virtual 2D gel picture [10] .
We used online databases, e.g. Panther (www.pantherdb.org), UniProt, NCBI, and 'softberry' (http://linux1.softberry.com/ berry.phtml), to classify the functions of the iTRAQ-identified p60TRP-regulated proteins. STRING (Search Tool for the Retrieval of Interacting Genes, http://string-db.org/; Mus musculus , default mode) analysis was carried out to retrieve information about functional partnerships among proteins that constitute the core of complex cellular phenotypes in the transgenic p60TRP brain. Further biocomputational network analysis of the iTRAQidentified p60TRP-regulated proteins using the Ingenuity Pathways Analysis (IPA, http://www.ingenuity.com) offered us additional valuable clues about the complex interactive link of these proteins in the brain.
Statistical Analysis
The data obtained in the Western blot analyses in this investigation are illustrated as means 8 SD, and Student's t test was applied. IBM-SPSS (IBM Statistical Products and Service Solutions) for Windows version 19 was used to perform ANOVA followed by Fisher's protected least significant difference post hoc tests, when warranted. For the iTRAQ analysis, ProteinPilot Software 3.0 was used. To be considered statistically significant, we required a probability value to be at least ! 0.05 (95% confidence limit, p ! 0.05) [5, 8, 9] .
Results
Identification of p60TRP-Regulated Proteins in Mouse Brain Cx and Hp
Through iTRAQ we identified a total of 2,025 proteins (Cx and Hp), whereby 1,735 proteins were quantified [with a strict cut-off of unused ProtScore 6 2 as the qualification criteria, which corresponds to a peptide confidence level of 99% and an applied false discovery rate of 0.33% ( ! 1.0%)]; out of 1,735 proteins 56 (Cx and Hp) showed altered protein expression levels that exhibited common trends for both transgenic mouse lines ( fig. 1 , tables 1-3 , online suppl. tables; the cut-off for up-and downregulation was predefined at 1.2 and 0.83, respectively).
In particular, 24 proteins were significantly modulated in the Cx ( 
Biocomputational Classification of p60TRP-Regulated Proteins
During the classification process, our objective was also to identify the proteins' subcellular localization and action ( fig. 2-4 ; tables 1-3 ). While the 56 regulated proteins had a reasonable distribution in terms of biological process, molecular function and protein class ( fig. 2 ) , it is of interest to note that a substantial portion of the identified proteins that were specifically affected in the Hp were oxidoreductases (approx. 24%, fig. 3 c) , while none of the oxidoreductase subgroup proteins were altered in the Cx and, instead, the number of cytoskeletal proteins were enlarged in the Cx -hinting at enhanced synaptic plasticity (approx. 26%, fig. 2 c) . Interestingly, only in the Hp were p60TRP-regulated proteins linked with the plasma membrane. Our proteomic data from AD brain-region-specific studies of human samples also revealed significant alterations in extracellular and plasma membrane-associated proteins in the Hp [unpubl. data] . This implicates that a tight regulation of plasma membrane-associated proteins is a prerequisite for normal functioning of the Hp.
We also realized that some of the p60TRP-regulated proteins could be partially linked with various neurodegenerative diseases such as Parkinson's (PD) or Hunting- Th e list contains quantitative information of the proteins from transgenic p60TRP mouse Cx compared with wild-type mice. These proteins have met the criteria [i.e. unused ProtScore >2.0, false discovery rate of 0.33% (<1.0%), change in expression levels of at least 1.2-fold (upregulation) or at least <0.833-fold (downregulation)] as defined in the experimental procedures. Peptides = The total number of peptides identified with >95% confidence; wt = wild-type mice; tg = transgenic p60TRP mice; NCK = non-catalytic region of tyrosine kinase.
Protein IDs
Gene symbols T he list contains quantitative information of the proteins from transgenic p60TRP mouse Hp compared with wild-type mice. These proteins have met the criteria [i.e. unused ProtScore >2.0, false discovery rate of 0.33% (<1.0%), change in expression levels of at least 1.2-fold (upregulation) or at least <0.833-fold (downregulation)] as defined in the experimental procedures. Peptides = The total number of peptides identified with >95% confidence; wt = wild-type mice; tg = transgenic p60TRP mice. T he list contains quantitative information of the proteins from transgenic p60TRP mouse Hp and Cx compared with-wild type mice. These proteins have met the criteria [i.e. unused ProtScore >2.0, false discovery rate of 0.33% (<1.0%), change in expression levels of at least 1.2-fold (upregulation) or at least <0.833-fold (downregulation)] as defined in the experimental procedures. Peptides = The total number of peptides identified with >95% confidence; wt = wild-type mice; tg = transgenic p60TRP mice.
ton's diseases (e.g. Snca/b, Ndufv2, Dlg4 and Arf3; tables 1-3 ), familial amyotrophic lateral sclerosis, schizophrenia and depressive disorder, suggesting a convergent nature of neurodegenerative mechanisms, hence linking different types of neurodegenerative disorders.
Data Validation by Western Blot
Following the database search and classification of proteins, Western blots were performed on randomly selected proteins to verify the iTRAQ values. Ten proteins, (Snca, Sept2, Synj1, Acadl, Mtap2, Mbp, Sod1, Sncb, Tuba8 and Gapdh) were used for validation ( fig. 5 ). Gapdh was used as an internal control to ensure equal loading of the samples as its level was also unchanged in the iTRAQ analyses.
Remarkably, the Western blot images correlated very well and thus confirmed the iTRAQ values obtained.
Biocomputational Network Analyses
The networks formed by the interacting proteins provided us crucial scaffolds for modelling the brain 
Biological process
Immune system process 2% system level mechanisms of cellular events involved in p60TRP-mediated brain functions. It revealed the functional link among metabolically modulated proteins specifically regulated in the Cx and Hp, respectively ( fig. 6 , 7 ) . In particular, it shows the link between p60TRP and Cdk proteins -a possible pathway through which p60TRP can modulate synaptic plasticity [4, 11] , eventually via influencing the anaphase-promoting complex as shown previously by others [5, 12] -, and the link between p60TRP and Ipo5, thus implicating a potential role of p60TRP within the nucleus. Besides, p60TRP's influence on oxidoreductases (Nduf, Sod1) and heat shock proteins (Hspd1 and Hspe1) may make the vulnerable Hp more stable against oxidative stress ( fig. 7 ) . Moreover, the physical interaction of p60TRP with Pp2ca connects it with several essential and life- sustainable metabolic processes such as survival, synaptogenesis and long term potentiation. Considering p60TRP's influence on AD-related signalling [4] , IPA could demonstrate p60TRP's impact on cortical and hippocampal proteins and the affected network with synaptic plasticity-relevant proteins such as Ntm, Ntrk1, Lsamp, Mtap2, Snca, Synj1/2, Syn2 and others ( fig. 8 ).
Discussion
GPCRs are considered as the largest superfamily of membrane proteins that translate extracellular signals into intracellular messages and serve as one of the best targets for diverse therapeutic applications. p60TRP has recently been found as novel member of the GPRASP family [3] and the in vivo relevance of p60TRP-dependent 
Biological process
Immune system process 2% signalling has also begun to be verified in a mouse model overexpressing neuronal p60TRP [4] . Further considering p60TRP's neuroprotective effects in AD, one could predict its feasibility in the treatment of AD as well as other neurodegenerative disorders. Hence, here we investigated in vivo the long-term effect of neuronal p60TRP overexpression on the brain-region-specific proteome metabolism. Successively, 56 proteins with altered expression were identified in the Hp and Cx of transgenic p60TRP mice. In the following sections, the specific functional roles of several of these iTRAQ-identified proteins, their rele- vance to brain diseases and the potential consequences of their p60TRP-mediated modified expressions are discussed.
Neuronal p60TRP Expression Specifically Mediates the Regulation of Cortical Proteins Crucially Involved in Brain Functions
Gria2 Protein The Gria2 gene product (also known as GluA2, GluR-K2, GluR2 or GluR-B) belongs to a family of ionotropic glutamate receptors (GluRs) that are sensitive to ␣ -amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. Regulation of AMPA receptors (AMPARs) has emerged as a key mechanism of long-term potentiation and long-term depression during processes related to synaptic plasticity [13, 14] . Analysis from post-mortem brains revealed a particularly prominent reduction of AMPAR subunit Gria1 and Gria2 expression in the prefrontal Cx of patients with schizophrenia. This finding supports and expands the hypothesis of glutamatergic dysfunction in the Cx during pathophysiological processes of schizophrenia [15] . Taken together, p60TRP may enhance synaptic plasticity through its positive impact on Gria2. Thus, interference with the cross-talk between p60TRP-GPCR and AMPAR signalling pathways may eventually become of interest for the treatment of diseases such as schizophrenia. Rin1 Protein Rin proteins serve as guanine nucleotide exchange factors for Rab5 GTPases. Rin1 is the prototype of this new family that has been shown to play an important role in the endocytosis of various receptors including the epidermal growth factor receptor [16] [17] [18] [19] . Rin1 is preferentially expressed in postnatal forebrain neurons in which it is localized in dendrites and physically associated with Ras, suggesting a role in Raf-Mek-Erk-pathway-mediated postsynaptic neuronal plasticity. It has been shown that Rin1 modulates neuronal plasticity in forebrain neurons where it blocks fear conditioning and amygdala longterm potentiation to inhibit the acquisition of fear memories [20] [21] [22] . The results indicate that Rin1 serves as an inhibitory modulator of neuronal plasticity in aversive memory formation [23] . An underlying mechanism of Rin1 function in amygdala is to downregulate EphA4 signalling by promoting its endocytosis [24] . Accordingly, p60TRP may strengthen synaptic plasticity through the downregulation of Rin1. Moreover, p60TRP mice revealed higher tendency to explore their surroundings and reduced Rin1 activity would serve as a tool to provoke acquisition of fear conditioning; hence, p60TRP mice are more clever compared to their wild type littermates.
Dmxl2 Protein Dmxl2 binds both GDP/GTP exchange protein and GTPase-activating protein for the Rab3 small G protein family that regulates Ca 2+ -dependent exocytosis of neurotransmitters [25, 26] , Dmxl2 is also a functional regulator of mammalian Notch signalling [27] , and thereby modulating neurogenesis [28, 29] . Its upregulation by p60TRP may cause enhanced neuronal synaptic activities resulting in increased synaptic plasticity. Basp1 Protein Similar to Gap43, the brain abundant membrane-attached signal protein 1 (Basp1) is intensively present in nerve endings [30] , and increased expression has been associated with the neuritic and synaptic dysfunction and pathogenesis of schizophrenia [31] . p60TRP-mediated downregulation of Basp1 might be associated with normal synaptic functions mediating neuroprotection.
Sncb Protein
Among the proteins downregulated in p60TRP transgenic mouse brains was Sncb, a protein involved in neurotransmitter release from nerve terminals and in the integration of signal transduction and membrane vesicle trafficking at nerve terminals. The synucleins ( ␣ , ␤ and ␥ ) are highly homologous proteins thought to play a role in regulating neurotransmission and are found abundantly in presynaptic terminals [32] . Besides, the proteins have the functional ability to induce membrane curvature and to convert large vesicles into highly curved membrane tubules and are thus involved in vesicle trafficking and endocytosis [33] . The Sncb protein is highly homologous to Snca and has been shown to be highly expressed in the substantia nigra of the brain, a region of neuronal degeneration in patients with PD; however, no direct relation to PD has been established; in contrast, Sncb rather inhibits Snca protein aggregation [34] [35] [36] .
Sept6 Protein
Septins are an evolutionarily conserved group of GTP-binding and filament-forming proteins that belong to the large superclass of P-loop GTPases. Recent studies reveal that septins associate with microtubules, microtubule-associated proteins and microtubule motors, and are also involved in dendritic spine formation [37, 38] . Additionally, they are involved in processes controlling neurotransmitter release [39] . Functions identified to date include also cell apoptosis, DNA damage response, vesicle trafficking, cytoskeletal reorganization and membrane dynamics, and alterations of these septin GTPase scaffolds, by mutation or expression changes, have also been associated with a variety of neurological disorders such as AD and PD [40] [41] [42] . For Sept6 it could be demonstrated that it has an increase in expression from embryonic day 15 to postnatal day 70, and is abundantly expressed in axons and growth cones of developing neurons, found in neuronal vesicles of presynaptic terminals [43] . In addition, it has been shown that the transmembrane myelin protein Mal interacts with the cytoskeleton protein Sept6 for membrane compartmentalization in myelin internodes [44] . The significance of its upregulation by p60TRP, however, needs further investigations.
Slc12a5 Protein
Slc12a5 is an integral membrane K + -Cl -cotransporter that can function in either a net efflux or influx pathway, depending on the chemical concentration gradients of K + and Cl -. The encoded protein can act as a homomultimer or as a heteromultimer with other K + -Cl -cotransporters, to maintain Cl -homeostasis in neurons. Increase expression in Slc12a5 correlates with the previous findings of an increased vesicular glutamate transporter Slc17a7 [4] and is pivotal for the maturation of the CNS GABAergic neurotransmission system [45, 46] . 14-3-3 Protein ␥ 14-3-3 Protein ␥ (Ywhag) belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. It has been shown to interact with Raf1 and protein kinase C, proteins involved in various signal transduction pathways. Ywhag interacts with Lrrk2 (leucine-rich repeat protein kinase 2) and Syna to protect dopaminergic neurons from ␣ -synuclein toxicity. Ywhag's downregulation is probably associated with the reduced expression of Snca/b [47, 48] . An upregulation might rather cause oncogenic Mapk and Pi3k signalling activation and cell transformation [49] . Similarly, the p60TRP-induced inhibition of Actr1b could be linked to the regulation of Snca/b [50] .
Arf3 Protein ADP ribosylation factors are highly conserved approximately 20-kDa guanine nucleotide-binding proteins that play crucial roles in neuronal intracellular vesicular transport and in regulations of phospholipidmodifying enzyme activities and cytoskeletons [51, 52] . Findings by Suzuki et al. [53] suggest that ADP ribosylation factors are differentially involved in some processes essential to nerve regeneration as well as neuronal differentiation and maturation. Thus, the regulatory influence of p60TRP on Arf3 could have a wider impact on neuronal differentiation (e.g. neuronal stem cells activated and recruited to affected areas upon nerve injury) and neuronal regeneration in the CNS.
Tuba8 Protein
It is conceivable that despite its low expression level in the CNS, Tuba8 serves some unique function that is es-sential to the developing brain, and mutations in Tuba8 might be involved in polymicrogyria and optic nerve hypoplasia [54] .
Ppp2ca Protein Increased expression of Ppp2ca correlates with higher protein phosphatase 2A activity in transgenic p60TRP mice and is of interest in view of AD-related signalling [4] though other recent findings report that a genetic variation in the tau protein phosphatase-2A pathway is not associated with AD risk [55] .
Gap43 Protein GAP43 promotes axon growth by multiple synergistic mechanisms that potentiate the intrinsic motility of the elongating processes, while reducing their sensitivity to environmental inhibition [56, 57] .
Ptms Protein
Ptms is a ubiquitous small acidic nuclear protein that is thought to be involved in cell cycle progression, proliferation and cell differentiation though is function in the brain is still unknown [58] . Data suggest a role of Ptms in the remodelling of higher-order chromatin structure through modulation of histone H 1 interaction with nucleosomes and point to its involvement in chromatin-dependent functions [59] .
Neuronal P60TRP Expression Specifically Mediates the Regulation of Hippocampal Proteins Crucially Involved in Brain Functions
Ndufv2 Protein The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyses the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. Ndufv2 encodes the 24-kDa subunit of complex I and is involved in electron transfer. Mutations in Ndufv2 are implicated in PD, bipolar disorder and schizophrenia [60] [61] [62] [63] [64] [65] [66] .
Dlg4 Protein Dlg4 (also known as PSD95) is a member of the membrane-associated guanylate kinase family and is recruited into N-methyl-D -aspartate receptor (NMDAR) and potassium channel clusters to regulate the strength of synaptic activity. Dlg4 interacts with several other scaffolding proteins to serve as anchorages also for ionotropic AMPAselective GluRs such as Gria2 [67] . Modifications of Dgl proteins function in the glutamatergic synapse, such as alterations of their interaction with NMDAR regulatory subunits, and are common events in several neurodegenerative disorders [68] [69] [70] [71] . Decreased expression of NM-DAR-associated proteins has been found in the frontal Cx of elderly patients with schizophrenia [72] while decreased levels of Dlg4 have been reported in the Hp from subjects with amnestic mild cognitive impairment [73] and in the inferior temporal Cx of AD subjects [74] ; in contrast, a significant increase in Dlg4 protein in Brodmann's area 9 of AD patients suggests a brain-site-specific change in NMDAR trafficking and may represent a novel marker of functional significance for the disease [75] . TrkB receptor and PKM , two critical regulators of synaptic plasticity, facilitate Dlg4 targeting to synapses [76] . Thus, p60TRP can influence synaptic plasticity directly via modulation of ionotropic AMPARs (Gria2) and/or indirectly via its modulatory role on Dlg4/NMDAR levels.
Camk2a Protein
The Ca 2+ /calmodulin-dependent serine/threonine protein kinase Camk2a is crucial for several aspects of plasticity at glutamatergic synapses such as hippocampal NMDAR-dependent long-term potentiation and spatial learning [77] . Postsynaptic secretion of brain-derived neurotrophic factor and neurotrophin-3 from hippocampal neurons also depends on Camk2, Ca 2+ and protein kinase A signalling [78] . Camk2a deficiency causes an immature dentate gyrus, dysregulated behaviours and impaired neuronal development as observed in psychiatric disorders [79] .
Another interesting point is that active proteolysis by the ubiquitin-proteasome pathway system has emerged as a new molecular mechanism that controls synaptic plasticity [80] . Besides, the neuronal ubiquitin-proteasome pathway system is itself rapidly and dynamically regulated by synaptic activity. Blockade of action potentials inhibits the activity of the proteasome, whereas the up-regulation of action potentials increases the activity of the proteasome. Camk2a stimulates proteasome activity and directly phosphorylates Rpt6, a subunit of the 19S (PA700) subcomplex of the 26S proteasome. This is a novel mechanism whereby p60TRP can influence Camk2a activity that may regulate the proteasome in neurons to facilitate remodelling of synaptic connections through protein degradation [81] . Since p60TRP mediates the upregulation of excitatory ionotropic GluR signalling mechanisms via Dlg4 and Gria2, the downregulation of Camk2a might be via a feedback loop to control synaptic plasticity in order to avoid excitatory neurotoxicity [82] [83] [84] [85] .
Sod1 Protein Sod1 binds copper and zinc ions and is one of two isozymes responsible for scavenging free superoxide radicals/reactive oxygen species in the cell. Mutant Sod1 has been associated with familial amyotrophic lateral sclerosis [86, 87] . The upregulation of Sod1 might also be via a feedback loop to control synaptic plasticity in order to avoid excitatory neurotoxicity mediated by oxidative stress and reactive oxygen species due to the enhanced levels of Gria2 and Dlg4 [85, 88] .
Sept9 Protein Sept9 can substitute for septins of the Sept2 group and partially for Sept7 [42, 89] . Since Sept9 is a member of the cytoskeleton-related septin family, which is highly expressed in glia cells in neuronal tissues, neuronal p60TRP modulates also glia functions. Sept9 is thought to function through interaction with other septins and small GTPase rho-mediated signalling. Sequence alterations in Sept9 are known to cause hereditary neuralgic amyotrophy. Sequence variations in Sept9 causing hereditary neuralgic amyotrophy are thus likely to alter modes of interaction with partner molecules in cells, and consequently contribute to the pathogenesis of hereditary neuralgic amyotrophy [90] [91] [92] . While p60TRP mediated reduced Sept9 expression levels, its overexpression would probably cause malignant brain glia tumors [93] .
Neuronal p60TRP Expression Specifically Mediates the Regulation of Cortical and Hippocampal Proteins Crucially Involved in Brain Functions
Synj1 Protein Endocytosis of the synaptic vesicle is a complicated process, in which many proteins and lipids participate. Phosphatidylinositol 4,5-bisphosphate [PI(4,5)P 2 ] plays important roles in the process, and the dynamic regulation of this lipid is one of the key events. Synj1 is the major constitutively active phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase in rodent brain that regulates the levels of membrane PI(4,5)P 2 [94] . Cyclin-dependent kinase 5 phosphorylates Synj1 and inhibits the inositol 5-phosphatase activity of Synj1, whereas dephosphorylation by calcineurin stimulates such activity [95] .
Besides, SYNJ1 maps to human chromosome 21 and is thus a candidate for an involvement in the AD-related disease Down's syndrome, a complex disorder resulting from the overexpression of trisomic genes. PI(4,5)P 2 metabolism is altered in the brain of Ts65Dn mice, the most commonly used model of Down's syndrome. This defect is rescued by restoring Synj1 to disomy in these Ts65Dn mice and is recapitulated in transgenic mice overexpressing Synj1. These transgenic mice also exhibit cognitive deficits, suggesting that PI(4,5)P 2 dyshomeostasis caused by a gene dosage imbalance for Synj1 may contribute to brain dysfunction and cognitive disabilities in Down's syndrome [96] . In addition, mutation analysis of SYNJ1 revealed it as a possible candidate gene for chromosome 21q22-linked bipolar disorder [97] .
Acadl Protein Long-chain acyl-CoA dehydrogenase (Acadl or LCAD) belongs to the acyl-CoA dehydrogenase family, which is a family of mitochondrial flavoenzymes involved in the first step of long-chain fatty acid ␤ -oxidation and branched chain amino-acid metabolism. This protein is one of the 4 enzymes that catalyse the initial step of mitochondrial ␤ -oxidation of straight-chain fatty acid. Defects in this gene are the cause of LCAD deficiency, leading to non-ketotic hypoglycaemia [98, 99] . Long-chain fatty acids are an important source of energy; however, the role of long-chain fatty acid oxidation in the brain (that does not rely on fat for energy) is poorly understood. Compartmentalization of acyl-CoA dehydrogenases in the human CNS suggests that ␤ -oxidation in the brain participates in different functions other than generating energy, for example the synthesis and/or degradation of unique cellular lipids and catabolism of aromatic amino acids, compounds that are vital to neuronal function; e.g. it may play a role in the turnover of lipid membrane unsaturated fatty acids that are essential for membrane integrity and structure [100, 101] .
Sept2 Protein
As other -GTPases [102, 103] , Sept2 is crucially involved in modelling neurite outgrowth during neuronal differentiation and a tight regulation of it expression is necessary [104] . Similarly to a number of other proteins that are related to G-protein-signalling pathways, such as Ranbp1, Rin1 and Sept9, p60TRP downregulates Sept2 in the Cx and Hp during a receptor (e.g. Gria2) resensitisation process. The observation that Sept6 is upregulated in the Cx might be another spatial brain-region-specific event that needs to be investigated further.
Mtap2 Protein
Mtap2 regulates and organizes microtubules and may serve as a scaffolding protein for neuromodulatory activities. Neuronal activity-dependent dynamic changes of microtubules are important to maintain neuronal morphology and function and are spatial and temporaldependent processes during synaptic plasticity [105] . A spatially and temporally dependent downregulation of indices of dendrites and spines, such as Mtap2, during neurosynaptic plasticity processes has been reported previously [106] . Additionally, a high Mtap2-associated microtubule turnover that accompanies synaptic plasticity and memory formation might be another reason for a temporal/spatial change in Mtap2 levels in the Cx and Hp [107] . Further experiments have also to identify the specific Mtap2 isoforms involved in this mechanism.
Snca Protein ␣ -Synuclein is a member of the synuclein family, which also includes ␤ -and ␥ -synuclein. Synucleins are abundantly expressed in the brain and ␣ -and ␤ -synucleins inhibit phospholipase D 2 selectively. Snca may serve to integrate presynaptic signalling and membrane trafficking. Snca is a natively unfolded protein which plays a central role in the control of dopaminergic neuronal functions and which is thought to be critically implicated in PD pathophysiology. Defects in Snca have been implicated in the pathogenesis of PD [108] . PD is characterized by a progressive loss of dopaminergic neurons of the nigrostriatal system and by the presence of Lewy bodies, proteinaceous inclusions mainly composed of filamentous Snca aggregates. Indeed, besides the fact that Snca is the main protein component of Lewy bodies, genetic studies showed that mutations and multiplications of the Snca gene are responsible for the onset of familial forms of PD. A large body of evidence indicates that Snca pa-
␣-Synucleinopathy
Prognosis -Ischaemic stroke 146 thology at dopaminergic synapses may underlie the onset of neuronal cell dysfunction and degeneration in the PD brain, particularly neurodegeneration caused by presynaptic Snca aggregation [109, 110] . In addition, abnormalities of Snca and NMDARs are implicated in the pathogenesis of PD through mechanisms involving oxidative stress and excitotoxicity as Snca may promote clathrinmediated NMDAR endocytosis [111, 112] and large Snca oligomers enhance both pre-and post-synaptic AMPARmediated synaptic transmission, thereby aggravating intracellular calcium dyshomeostasis and contributing to excitotoxic nerve cell death in synucleinopathies [113] .
In conclusion, neuronal p60TRP overexpression may contribute to improved cognitive functions by promoting synaptic proteins such as Gria2 or Dmxl2 [4] . p60TRP's potential to modulate temporal and spatial brain-sitespecific signalling pathways related to synaptic plasticity and neuroregenerative processes ( fig. 9 ) may thus open new therapeutic avenues for the treatment of various CNS diseases such as AD, PD, amyotrophic lateral sclerosis, bipolar disorder or schizophrenia.
